Accessibility Menu
 

Why Synergy Pharmaceuticals Is Jumping 10% Today

Investors are increasingly optimistic that plecanatide can reshape treatment for gastrointestinal disorders.

By Todd Campbell Updated Dec 23, 2016 at 11:30AM EST

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.